Citadel Advisors - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$29,191,945
+2.8%
1,839,442
+22.2%
0.01%0.0%
Q2 2023$28,403,879
+379.8%
1,505,240
-2.4%
0.01%
+500.0%
Q1 2023$5,920,351
+327.3%
1,541,758
+452.0%
0.00%
Q4 2022$1,385,443
-82.1%
279,323
-82.8%
0.00%
-100.0%
Q3 2022$7,761,000
-14.0%
1,623,709
-19.1%
0.00%0.0%
Q2 2022$9,028,000
+55.1%
2,006,141
+64.0%
0.00%
+100.0%
Q1 2022$5,822,000
-38.0%
1,222,968
-3.4%
0.00%
-50.0%
Q4 2021$9,390,000
+886.3%
1,265,451
+653.2%
0.00%
Q3 2021$952,000
-80.9%
168,000
-77.8%
0.00%
-100.0%
Q2 2021$4,984,000
+55.2%
756,364
+90.7%
0.00%
Q1 2021$3,212,000
-72.9%
396,580
-78.4%
0.00%
-100.0%
Q4 2020$11,845,000
+374.2%
1,836,547
+164.6%
0.00%
+200.0%
Q3 2020$2,498,000
+133.0%
694,019
+197.8%
0.00%
Q2 2020$1,072,000
-56.4%
233,056
-67.7%
0.00%
-100.0%
Q1 2020$2,457,000
-64.0%
720,464
-46.2%
0.00%
-66.7%
Q4 2019$6,830,000
+404.8%
1,337,991
+139.3%
0.00%
+200.0%
Q3 2019$1,353,000
-42.9%
559,144
-48.8%
0.00%0.0%
Q2 2019$2,371,000
+55.7%
1,092,420
+94.5%
0.00%
Q1 2019$1,523,000
-88.7%
561,792
-79.9%
0.00%
-100.0%
Q4 2018$13,434,000
-41.1%
2,798,704
+16.2%
0.01%
-30.0%
Q3 2018$22,813,000
+16.2%
2,408,876
+19.4%
0.01%
+11.1%
Q2 2018$19,635,000
+225.2%
2,018,028
+251.7%
0.01%
+200.0%
Q1 2018$6,037,000
+334.6%
573,832
+164.9%
0.00%
+200.0%
Q4 2017$1,389,000
-33.9%
216,649
-21.1%
0.00%0.0%
Q3 2017$2,101,000
+464.8%
274,639
+424.1%
0.00%
Q2 2017$372,000
+69.1%
52,400
-7.7%
0.00%
Q1 2017$220,000
-50.6%
56,800
-73.9%
0.00%
Q4 2016$445,000
-23.9%
218,018
-0.1%
0.00%
Q3 2016$585,000
+13.6%
218,185
+30.6%
0.00%
-100.0%
Q2 2016$515,000
+32.4%
167,102
+312.6%
0.00%
Q3 2015$389,000
-79.6%
40,502
-69.4%
0.00%
-100.0%
Q2 2015$1,904,000
+133.3%
132,435
+45.2%
0.00%
+100.0%
Q1 2015$816,000
-28.5%
91,180
-51.3%
0.00%0.0%
Q4 2014$1,142,000
-16.4%
187,152
+45.1%
0.00%0.0%
Q3 2014$1,366,000
-24.2%
129,004
-15.2%
0.00%
-50.0%
Q2 2014$1,802,000
+23.3%
152,048
+55.2%
0.00%0.0%
Q1 2014$1,462,000
+5.9%
97,943
+4.1%
0.00%0.0%
Q4 2013$1,380,000
+73.1%
94,075
+101.0%
0.00%
+100.0%
Q3 2013$797,000
+254.2%
46,801
+244.4%
0.00%
Q2 2013$225,00013,5880.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders